Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021.
Corporate Participants:
Jody Cain — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Analysts:
Michael Okunewitch — Maxim Group — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was